Inflammation as a Sensor of Metabolic Stress in Obesity and Type 2 Diabetes
The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
It is broadly accepted that the main cause of type 2 diabetes is overfeeding. Unclear is how this metabolic stress is translated into signals leading to defective insulin secretion and action. Increasing evidence points to a role of the innate immune system in sensing changes in nutrient levels. This results in an inflammatory process that has been proposed to contribute to the pathogenesis of type 2 diabetes (1). At the origin of this process, activation of the IL-1 pathway seems to play a central role. Processing of pro-IL-1β to IL-1β is controlled by the inflammasome (see below) as a response to sensing danger signals. In this issue of Endocrinology, Youm and colleagues (2) demonstrates that the inflammasome mediates islet inflammation induced by high-fat feeding. Activation of the innate immune system is the first response to tissue injury or aggression. It is characterized by release of cytokines and chemokines and immune cell invasion and is accompanied by functional or structural damage followed by tissue repair or fibrosis. This inflammatory process was originally thought to be caused by microbes or physical damages. However, in some cases, the innate immune system may attack the body's own tissues in the absence of an exogenous aggressor, resulting in a sterile inflammatory process, i.e. an autoinflammatory disease. In the pancreatic islet, metabolic stress may also elicit such a response. Indeed, glucose, free fatty acids, and human islet amyloid polypeptide may induce IL-1β, launching a proinflammatory response impairing insulin production and secretion (3–6). Accordingly, blocking IL-1β improves insulin release and glycemia in prediabetic and diabetic patients (7, 8). The question arises of how metabolic stress is sensed by the IL-1 system. The inflammasome is a key factor mediating activation of innate immunity. It is a complex of several proteins that may activate caspase 1, which cleaves pro-IL-1β to IL-1β. Activation of IL-1β will then induce itself and a variety of cytokines and chemokines via nuclear factor-κB. Interestingly, the inflammasome can be activated by a variety of metabolic disturbance including uric acid during gout arthritis (9) and cholesterol in atherogenesis (10). In the context of diabetes, it has been shown that glucose and human islet amyloid polypeptide activates the inflammasome in pancreatic islets (5, 6, 11) and lipopolysaccharide, free fatty acids, and ceramides in adipose tissues (12–14). All of this assigns to the inflammasome a role as a sensor of metabolic stress. The above mentioned studies have convincingly shown the functional role of the inflammasome in insulin resistance (12–14). With respect to islet inflammation, animal and clinical studies have shown that reducing IL-1β activity improves insulin secretion (7, 8, 15, 16). However, it remained to be demonstrated that this involves the inflammasome. In the study by Youm and colleagues (2), it is shown that lack of the NLRP3 inflammasome protects from the development of islet fibrosis in mice on a high-fat diet. Because fibrosis is an end stage of a chronic inflammatory process, it may be assumed that the level of insulitis was decreased, although data on immune cell infiltration are missing in this study. Another weakness of the study is the lack of functional insulin secretion tests. However, islet mass and insulin release were improved in the NLRP3 knockout mice on a high-fat diet compared with wild-type controls. Therefore, it can be concluded that inflammasome is most probably a critical mediator of islet inflammation in obesity. Thus, unraveling the molecular mechanisms underlying induction of an inflammatory response during obesity and diabetes assigns to the innate immune system a new role in detecting metabolic dangers. The inflammasome appears as the sentinel sensing metabolic stress and alarming the immune defense in pancreatic islets, insulin-sensitive tissues, and blood vessels. It is likely that this inflammatory process has protective effects, but eventually, chronic inflammation will become deleterious. Future studies should aim at understanding in more detail this process to develop treatment modalities allowing a targeted use of antiinflammatory drugs such as IL-1β blockers and salsalate (7, 17). Disclosure Summary: The author has nothing to disclose.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Interleukin-1-receptor antagonist in type 2 diabetes mellitus
Larsen, C. M., Faulenbach, M., Vaag, A., Vølund, A., Ehses, J. A., Seifert, B., Mandrup-Poulsen, T., & Donath, M. Y. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa065213 · Cited by 1,798
Self-citationMasters, S. L., Dunne, A., Subramanian, S. L., Hull, R. L., Tannahill, G. M., Sharp, F. A., Becker, C., Franchi, L., Yoshihara, E., Chen, Z., et al. (2010) · Nature Immunology · doi:10.1038/ni.1935 · Cited by 1,330
Cited by
Profile of the Immune and Inflammatory Response in Individuals With Prediabetes and Type 2 Diabetes
Grossmann, V., Schmitt, V. H., Zeller, T., Panova-Noeva, M., Schulz, A., Laubert-Reh, D., Juenger, C., Schnabel, R. B., Abt, T. G. J., Laskowski, R., et al. (2015) · Diabetes Care · doi:10.2337/dc14-3008 · Cited by 257
Obesity-associated NLRC4 inflammasome activation drives breast cancer progression
Kolb, R., Phan, L., Borcherding, N., Liu, Y., Yuan, F., Janowski, A. M., Xie, Q., Markan, K. R., Li, W., Potthoff, M. J., et al. (2016) · Nature Communications · doi:10.1038/ncomms13007 · Cited by 239
Moderate weight loss in obese and overweight men preserves bone quality
Pop, L. C., Sukumar, D., Tomaino, K., Schlussel, Y., Schneider, S. H., Gordon, C. L., Wang, X., & Shapses, S. A. (2015) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.114.088534 · Cited by 47
Metadata
- Authors
- Donath, M. Y.
- Venue
- Endocrinology
- Publisher
- The Endocrine Society
- Published
- 2011-11-01
- Volume
- 152
- Issue
- 11
- Pages
- 4005-4006
- ISSN
- 0013-7227 (ISSN-L)
- 1945-7170
- OpenAlex
- W2112637644
- Cited by
- 41
- References
- 2
- FWCI
- 1.73
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Inflammation as a Sensor of Metabolic Stress in Obesity and Type 2 Diabetes. https://app.cochat.ai/papers/10.1210/en.2011-1691
- The paper
- Donath, M. Y. (2011). Inflammation as a Sensor of Metabolic Stress in Obesity and Type 2 Diabetes. Endocrinology. https://doi.org/10.1210/en.2011-1691
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.